Abstract

Recent characterization of spatiotemporal genomic architecture of IDH-wild-type multifocal glioblastomas (M-GBMs) suggests a clinically unobserved common-ancestor (CA) with a less aggressive phenotype, generating highly genetically divergent malignant gliomas/GBMs in distant brain regions. Using serial MRI/3D-reconstruction, whole-genome sequencing and spectral karyotyping-based single-cell phylogenetic tree building, we show two distinct types of tumor evolution in p53-mutant driven mouse models. Malignant gliomas/GBMs grow as a single mass (Type 1) and multifocal masses (Type 2), respectively, despite both exhibiting loss of Pten/chromosome 19 (chr19) and PI3K/Akt activation with sub-tetraploid/4N genomes. Analysis of early biopsied and multi-segment tumor tissues reveals no evidence of less proliferative diploid/2N lesions in Type 1 tumors. Strikingly, CA-derived relatively quiescent tumor precursors with ancestral diploid/2N genomes and normal Pten/chr19 are observed in the subventricular zone (SVZ), but are distantly segregated from multi focal Type 2 tumors. Importantly, PI3K/Akt inhibition by Rictor/mTORC2 deletion blocks distant dispersal, restricting glioma growth in the SVZ.

Recent studies suggest spatial segregation of tumor initiation and manifestation in IDH-WT glioblastomas. Here, the authors use serial MRI/3D-reconstruction, whole-genome sequencing and spectral karyotyping-based single-cell phylogenetic tree building to establish this unique evolutionary mode in a murine model.

Details

Title
Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution
Author
Li, Yinghua 1   VIAFID ORCID Logo  ; Li, Bo 2 ; Li, Wei 3 ; Wang, Yuan 4   VIAFID ORCID Logo  ; Akgül Seçkin 5   VIAFID ORCID Logo  ; Treisman, Daniel M 6   VIAFID ORCID Logo  ; Heist, Kevin A 7 ; Pierce, Brianna R 4 ; Hoff, Benjamin 7 ; Cheng-Ying, Ho 3 ; Ferguson, David O 8 ; Rehemtulla Alnawaz 9 ; Zheng Siyuan 10   VIAFID ORCID Logo  ; Ross, Brian D 7 ; Li, Jun Z 2   VIAFID ORCID Logo  ; Zhu, Yuan 11   VIAFID ORCID Logo 

 Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, USA 
 University of Michigan Medical School, Department of Human Genetics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 Center for Genetic Medicine Research, Children’s National Hospital, Washington, USA (GRID:grid.214458.e) 
 Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); Center for Cancer and Immunology Research, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); Center for Neuroscience Research, Children’s National Hospital, Washington, USA (GRID:grid.214458.e) 
 Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); Center for Cancer and Immunology Research, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); Center for Neuroscience Research, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); University of Michigan Medical School, Cellular and Molecular Biology Graduate Program, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); QIMR Berghofer Medical Research Institute, Sid Faithfull Brain Cancer Laboratory, Department of Cell and Molecular Biology, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395) 
 Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, USA (GRID:grid.1049.c); Center for Cancer and Immunology Research, Children’s National Hospital, Washington, USA (GRID:grid.1049.c); Center for Neuroscience Research, Children’s National Hospital, Washington, USA (GRID:grid.1049.c); University of Michigan Medical School, Cellular and Molecular Biology Graduate Program, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Department of Radiology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Department of Pathology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Department of Radiation Oncology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
10  The University of Texas Health Science Center at San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
11  Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); Center for Cancer and Immunology Research, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); Center for Neuroscience Research, Children’s National Hospital, Washington, USA (GRID:grid.214458.e); University of Michigan Medical School, Cellular and Molecular Biology Graduate Program, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); The George Washington University, GW Cancer Center, Washington, USA (GRID:grid.253615.6) (ISNI:0000 0004 1936 9510) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2426013273
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.